Hematology NewsSCD, beta-thalassemia: CRISPR-based gene therapy `transformative’July 10, 2023Mixed TopicsBleeding DisordersCellular Therapy
Hematology NewsESMO helps hematologists assess new cancer drugsJune 28, 2023Mixed TopicsCellular TherapyCMLCLLAggressive LymphomasALLAML
Oncology PracticeHuge underuse of germline testing for cancer patientsJune 22, 2023Patient & Survivor CarePreventive CareBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal Cancer
Hematology NewsWomen hematologists advance MM research, give backJune 15, 2023Multiple MyelomaCellular TherapyDiversity in Medicine
Hematology NewsCAR-T hikes overall survival in relapsed/refractory LBCLJune 9, 2023B Cell LymphomaCellular Therapy
Hematology News`Remarkable’: CAR T therapy for CLL/SLLJune 8, 2023CLLB Cell LymphomaNon-Hodgkin LymphomaCellular Therapy
Hematology NewsFDA OKs stem cell therapy for blood cancer patients to reduce infection risksApril 18, 2023Cellular TherapyTransplant
Hematology NewsVenetoclax shows promise for r/r hairy cell leukemiaMarch 10, 2023Mixed TopicsCLLAMLCellular Therapy
Hematology NewsInclusive reminder: LGBTQ community may donate stem cellsMarch 8, 2023Cellular TherapyMixed TopicsTransplant
Hematology NewsHigh cost and demand for old cancer drug sparks crisisDecember 5, 2022CLLCellular TherapyMantle Cell Lymphoma
Hematology NewsGloom lifting as MCL treatments evolveOctober 21, 2022Mantle Cell LymphomaCellular TherapyMixed Topics
Hematology NewsCAR T-cell therapy neurotoxicity linked to NfL elevationsOctober 3, 2022Cellular TherapyAggressive LymphomasALLB Cell LymphomaMultiple MyelomaMixed TopicsCLL
Hematology NewsNovel approach brings hospice-bound MM patient into remissionSeptember 29, 2022Multiple MyelomaCellular TherapyMixed Topics
Hematology NewsMany die waiting for `last-chance’ therapyAugust 2, 2022Multiple MyelomaAggressive LymphomasALLCLLCellular TherapyMixed Topics
